Posted by on Jul 31, 2022 in Blog, Colorectal cancer |

Fourteen people no longer have stage 2 or 3 rectal cancer because of an experimental use of immunotherapy.  Enrolling in a clinical trial has, for the past 25 months and counting, spared them from surgery, chemotherapy, and radiation, which are the standard treatments for colorectal cancer.  [1] Fourteen people may not sound like many, but it...

Read More